p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer
Head and neck squamous cell carcinoma (HNSCC) constitutes one of the most common types of human cancers and often metastasizes to lymph nodes. Platinum-based chemotherapeutic drugs are commonly used for treatm...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Abdulkader Yassin-Kassab, Suman Chatterjee, Nayel Khan, Nathaniel Wang, Vlad C. Sandulache, Eric H-B. Huang, Timothy F. Burns and Umamaheswar Duvvuri Tags: Research Source Type: research
More News: Burns | Cancer | Cancer & Oncology | Carcinoma | Head and Neck Cancer | HNSCC | Skin Cancer | Squamous Cell Carcinoma